{{Rsnum
|rsid=2033547
|Gene=MEF2A
|Chromosome=15
|position=99674753
|Orientation=minus
|GMAF=0.3976
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=MEF2A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 18.8 | 62.5 | 18.8
| HCB | 14.0 | 37.2 | 48.8
| JPT | 20.5 | 47.7 | 31.8
| YRI | 3.3 | 14.8 | 82.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 14.0 | 37.2 | 48.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|19135199|OA=1
}} Higher lipoprotein-associated phospholipase predicts cardiovascular disease [[rs2033547]] [[rs1051931]] [[rs10520358]]

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}